Jyong Biotech Ltd (MENS)

Dec 10, 2025

Jyong Biotech Shares Becomes Oversold (MENS) - Nasdaq

Dec 10, 2025

Dec 08, 2025

Jyong Biotech Ltd.’s (NASDAQ:MENS) Lock-Up Period Will End on December 15th - Defense World

Dec 08, 2025

Dec 07, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap Down – Here’s Why - Defense World

Dec 07, 2025

Dec 06, 2025

Taiwan's Jyong Biotech expands regional partnership with MoU signing in Vietnam - BioSpectrum Asia

Dec 06, 2025

Dec 05, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 4.3%Time to Sell? - MarketBeat

Dec 05, 2025

Dec 04, 2025

Jyong Biotech expands regional partnerships, signs MoU with a Vietnam pharmaceutical distributor - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor - TradingView

Dec 04, 2025

Dec 04, 2025

Jyong Biotech (Nasdaq: MENS) signs Vietnam MCS-2 MOU, advancing Asia plan - Stock Titan

Dec 04, 2025

Dec 03, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap UpWhat's Next? - MarketBeat

Dec 03, 2025

Dec 02, 2025

Jyong Biotech (MENS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 02, 2025

Jyong Biotech (NASDAQ:MENS) Trading Up 15.1%Here's What Happened - MarketBeat

Dec 02, 2025

Nov 27, 2025

Jyong Biotech: Speculative BPH And Prostate Cancer Prevention Story (NASDAQ:MENS) - Seeking Alpha

Nov 27, 2025

Nov 26, 2025

Jyong Biotech (NASDAQ:MENS) Stock Price Down 9.6%What's Next? - MarketBeat

Nov 26, 2025

Nov 26, 2025

Taiwan's Jyong Biotech announces partnership in Korea to evaluate in‑licensing of plant-derived MCS drugs - BioSpectrum Asia

Nov 26, 2025

Nov 25, 2025

Jyong Biotech signs letter of intent with South Korean pharma company - Investing.com Australia

Nov 25, 2025

Nov 24, 2025

Jyong Biotech to Evaluate Licensing Deal for MCS-2 Drug Candidate in South Korea - marketscreener.com

Nov 24, 2025

Nov 24, 2025

Jyong Biotech signs letter of intent with South Korean pharma company By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs - The Manila Times

Nov 24, 2025

Nov 24, 2025

Jyong Biotech (Nasdaq: MENS) LOI to Evaluate MCS-2 Licensing with Korean Pharma - Stock Titan

Nov 24, 2025

Nov 24, 2025

Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with - GlobeNewswire

Nov 24, 2025

Nov 21, 2025

Jyong Biotech (NASDAQ:MENS) Shares Up 10.9%Should You Buy? - MarketBeat

Nov 21, 2025

Nov 21, 2025

Jyong Biotech completes primary endpoint analysis for Phase II trial of MCS-8 - Yahoo Finance

Nov 21, 2025

Nov 21, 2025

Exploring Jyong Biotech’s (NasdaqGM:MENS) Valuation Following Recent Share Price Volatility - Yahoo Finance

Nov 21, 2025

Nov 20, 2025

Jyong Biotech reports positive results for prostate cancer drug in phase II trial - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Jyong Biotech stock soars after positive Phase II prostate cancer drug results - Investing.com Nigeria

Nov 20, 2025

Nov 20, 2025

Jyong Biotech stock soars after positive Phase II prostate cancer drug results By Investing.com - Investing.com South Africa

Nov 20, 2025

Nov 20, 2025

Jyong Biotech Says Phase 2 Trial of MCS-8 in Prostate Cancer Meets Efficacy Endpoints - marketscreener.com

Nov 20, 2025

Nov 20, 2025

Jyong Biotech announces completion of primary endpoint statistical analysis for phase II clinical trial of MCS-8 with positive outcomes - MarketScreener

Nov 20, 2025

Nov 20, 2025

Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes - The Manila Times

Nov 20, 2025

Nov 20, 2025

Jyong Biotech Announces Completion of Primary Endpoint - GlobeNewswire

Nov 20, 2025

Nov 19, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap DownTime to Sell? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Jyong Biotech Ltd. (MENS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 19, 2025

Nov 19, 2025

Jyong Biotech is Now Oversold (MENS) - Nasdaq

Nov 19, 2025

Nov 18, 2025

Jyong Biotech plunges 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com Australia

Nov 18, 2025

Nov 17, 2025

Google, Alibaba among market cap stock movers on Monday - Investing.com

Nov 17, 2025

Nov 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Nov 17, 2025

Nov 17, 2025

Google and Micron among market cap stock movers on Monday By Investing.com - Investing.com UK

Nov 17, 2025

Nov 17, 2025

Google and Micron among market cap stock movers on Monday - Investing.com India

Nov 17, 2025

Nov 13, 2025

Jyong Biotech (MENS US): Taiwan-Based, US-Listed, Excluded from US & Global Indices - Smartkarma

Nov 13, 2025

Nov 13, 2025

Jyong Biotech (NASDAQ:MENS) Trading Down 8%Here's Why - MarketBeat

Nov 13, 2025

Nov 12, 2025

Dow notches record-high close while tech-heavy Nasdaq slips - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Dow notches record high close, traders bet on end to shutdown - Yahoo Finance

Nov 11, 2025

Nov 10, 2025

Health insurers slide after subsidies dropped from US shutdown deal - Yahoo Finance

Nov 10, 2025

Nov 10, 2025

Global shares jump as investors eye potential end to US shutdown - Yahoo Finance

Nov 10, 2025

Nov 05, 2025

Wall Street ends higher on solid data, strong earnings - Yahoo Finance

Nov 05, 2025

Nov 03, 2025

OpenAI signs $38 billion deal to use Amazon's cloud platform - Yahoo Finance

Nov 03, 2025